What were the main technology trends at RSNA 2022?
December 15, 2022 -- There's no better economic barometer for the global medical imaging sector than the vast exhibition halls at the RSNA meeting. Industry guru Steve Holloway was in Chicago, and he reflects on the most important take-home messages. Read More
Meet the EuroMinnies 2023 semifinal candidates
December 14, 2022 -- The list of candidates for the fifth edition of the EuroMinnies awards scheme is now available, following the large number of nominations submitted by the members of AuntMinnieEurope.com. Find out who's made the shortlist in the nine categories. Read More
MRI-targeted prostate biopsies can drastically cut overdiagnosis
December 12, 2022 -- A new approach to prostate cancer biopsy based on targeted MRI rather than systemic ultrasound shows promise for reducing overdiagnosis by up to half, Swedish scientists stated on 8 December in the New England Journal of Medicine. Read More
Debate focuses on MRI contrast use in juvenile idiopathic arthritis
December 7, 2022 -- German researchers have reported that contrast agent can be omitted in juvenile idiopathic arthritis patients when using an augmented knee MRI protocol comprising proton density-weighted sequences. Read More
Susceptibility-weighted MRI shows brain changes in COVID-19 patients
December 7, 2022 -- Susceptibility-weighted MRI reveals that patients who have recovered from COVID-19 show changes in their brains up to six months later, according to research presented at the RSNA meeting in Chicago. Read More
Europeans dominate in global awards for top 2022 images
December 6, 2022 -- French and German researchers scooped the top prizes in the "Images in Radiology" collection. The winner was a cinematic 3D-rendered image of a woman with Marfan syndrome, while the runner up was given for MRI scans of a 15-year-old boy with myocarditis after COVID-19 vaccination. Read More
Support grows for use of abbreviated MRI in breast cancer screening
December 6, 2022 -- Abbreviated breast MRI can serve as a viable alternative to conventional MRI when it comes to high-risk supplemental screening, suggests research presented at the RSNA annual meeting in Chicago. Read More
Kuhl provides research update on gadolinium-based contrast agent
December 5, 2022 -- CHICAGO - Gadopiclenol is emerging as an alternative gadolinium-based MRI contrast agent. To learn more about the product's potential, we spoke with Prof. Dr. Christiane Kuhl from the University Hospital Aachen in Germany at RSNA 2022. Read More
Short MRI plus CT identifies colorectal cancer liver metastases
December 2, 2022 -- CHICAGO - An abbreviated MRI protocol combined with contrast-enhanced CT performs comparably to a standard MRI exam for identifying liver metastases in colorectal cancer patients, according to research presented on 30 November at the RSNA meeting. Read More
French group flies the flag for Europe in RSNA poster hall
December 1, 2022 -- Members of a research group in Nantes -- known as the jewel of the Loire Valley in northwest France -- received Europe's only magna cum laude award when the prestigious prizes were handed out on day 4 of the RSNA meeting. Read More